Slender Medical
Ultrasonic Technology for Noninvasive Tissue Removal
Company Overview
Snapshot
Founded in January 2007 by Jacob BenArie, Slender Medical operates with 1–10 employees. The company has secured funding across one round from one investor, Rainbow Medical. In June 2009, Slender Medical received seed funding from Rainbow Medical.
Business overview
Slender Medical is a medical device company developing ultrasonic technology for the noninvasive removal of tissue. The company's core technology focuses on well-monitored modalities to provide safe and effective applications for localized treatment of areas such as the chin and arm, which are often difficult to target with existing technologies. Additionally, Slender Medical's technology can address abnormal subdermal conditions like lipomas. The company operates within the Health Tech & Life Sciences sector, specifically in Medical Devices and Medical Treatment & Therapeutics, serving the global healthcare market.
Strategic signal
In June 2010, Slender Medical announced plans to commence clinical trials for its body shaping technology. This development signaled a critical step towards validating the efficacy and safety of its noninvasive ultrasonic tissue removal solutions, indicating progress in bringing its medical and aesthetic applications closer to market.
Log in to access full profile ›Company Intelligence Q&A
- When was Slender Medical founded?
- Slender Medical was founded in January 2007.
- Who is a co-founder of Slender Medical?
- Jacob BenArie is a co-founder of Slender Medical.
- What is Slender Medical's primary focus?
- Slender Medical focuses on developing ultrasonic technology for the noninvasive removal of tissue for medical and aesthetic markets.
- What significant development occurred in June 2010?
- In June 2010, Slender Medical was set to begin clinical trials for its body shaping technology.